Don Jacobson

A University of Minnesota idea for fighting mosquito-borne diseases such as Zika through editing the insects’ genomes shows broad commercialization potential, at least in the estimation of National Science Foundation funders.

When the University of Minnesota announced in April it had achieved a technological breakthrough by printing an electronic circuit directly onto the skin of a human hand, it made international news as readers and media viewers around the globe pondered its implications.

A new medical device being co-developed by the Mayo Clinic to treat an especially deadly type of stroke is on target for an initial U.S. Food and Drug Administration application in the next quarter, according to newly filed documents.

Mayo Clinic spin-off company Vyriad Inc., maker of genetically-engineered viruses designed to destroy cancer tumors, is raising $9 million to fund an expansion at the former IBM building in Rochester where it plans to hire and house up to 30 new employees.

The Mayo Clinic and a nonprofit genomics research group based in Phoenix have applied for patent protection on a promising drug-and-radiation method for treating deadly brain cancer, which they have hailed as a breakthrough.

The Mayo Clinic’s Biobank program, fresh off the launch of a nationwide government program to store 35 million donated bio-samples to advance the science of individualized medicine, has now also attracted a private-sector collaboration targeting Alzheimer’s disease.

Sustainable energy firm remakes the Jemne Building,...

After seven years, a couple reaches a turning point in reviving St. Paul’s oldest commercial structure — into the Stone Saloon

Obama celebrates hometown Chicago Blackhawks at Whi...